Laxmi Dental Limited Submits Q3 FY26 Monitoring Agency Report on IPO Proceeds Utilization

Laxmi Dental Limited has submitted its quarterly monitoring agency report for the quarter ended December 31, 2025, in compliance with SEBI regulations regarding IPO proceeds utilization. The report, prepared by ICRA Limited as the monitoring agency, provides a comprehensive overview of how the company has deployed funds raised through its Initial Public Offer. IPO Proceeds Utilization Overview The monitoring report reveals that Laxmi Dental has utilized INR 76.802 crore out of the total IPO proceeds of INR 138.000 crore during the reporting period. This leaves INR 61.198 crore as unutilized funds, which have been strategically deployed in fixed deposits to generate returns. Utilization Status: Amount (INR Crore) Total IPO Proceeds: 138.000 Amount Utilized: 76.802 Unutilized Amount: 61.198 Quarterly Utilization: 2.988 Object-wise Fund Deployment The company's IPO proceeds are being utilized across five key objectives as outlined in the prospectus. The debt repayment objectives have been fully completed, while machinery purchase requirements are still in progress. Object: Allocated (INR Crore) Utilized (INR Crore) Remaining (INR Crore) Status Company Debt Repayment: 22.984 22.984 - Complete Subsidiary Debt Investment: 4.600 4.600 - Complete Company Machinery Purchase: 43.507 6.973 36.534 In Progress Subsidiary Machinery Investment: 25.004 0.346 24.658 In Progress General Corporate Purposes: 32.075 32.075 - Complete Investment of Unutilized Funds The company has invested INR 62.525 crore of unutilized proceeds in fixed deposits with ICICI Bank, generating total earnings of INR 2.787 crore. The fixed deposits carry interest rates ranging from 2.75% to 7.30% with varying maturity dates extending up to December 2027. Key investment highlights include: 26 fixed deposits totaling INR 62.412 crore Interest earnings of INR 2.787 crore Market value of investments at INR 65.199 crore Balance in public offer account of INR 0.113 crore General Corporate Purpose Utilization The company has fully utilized INR 32.075 crore allocated for general corporate purposes across multiple categories: Payment of taxes and liabilities: INR 2.910 crore Debt repayment: INR 6.500 crore Creditor payments: INR 11.355 crore (across Q1 and Q3 FY26) Subsidiary investment (Bizdent Devices): INR 11.310 crore Compliance and Monitoring ICRA Limited, serving as the monitoring agency, confirmed that there is no material deviation from the objects of the issue. The utilization of proceeds remains in line with the disclosures made in the offer document. The company's IPO, which opened on January 13, 2025, and closed on January 15, 2025, raised INR 698.058 crore including the Offer for Sale portion. The monitoring agency noted that some machinery purchases are being conducted through different vendors than originally proposed in the prospectus, but confirmed this approach is consistent with the flexibility disclosed in the offer document. The report indicates that spending for capital expenditure objects is expected to continue in the current fiscal year. Laxmi Dental Limited has addressed stock exchange inquiries regarding unusual trading activity in its shares, confirming that recent volume increases are market-driven with no underlying corporate developments requiring disclosure. Exchange Communication Details The company received an inquiry from the National Stock Exchange of India (NSE) on January 20, 2026, at 6:10 PM seeking clarification on the increased trading volume in Laxmi Dental's securities. The response was formally communicated to both NSE and BSE on the same day. Parameter: Details NSE Symbol: LAXMIDENTL BSE Scrip Code: 544339 Inquiry Date: January 20, 2026 Response Time: Same day Regulatory Compliance Statement Laxmi Dental emphasized its commitment to regulatory compliance, stating that the company has been consistently making all requisite disclosures to stock exchanges in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company assured continued adherence to these regulations. Key Clarifications The company provided specific clarifications regarding the trading volume surge: No unpublished price sensitive information exists that requires disclosure under Regulation 30 of SEBI LODR Regulations No corporate events have become due for disclosure The volume movement in shares is purely market-driven All necessary regulatory disclosures have been made as required Corporate Information Laxmi Dental Limited, formerly known as Laxmi Dental Export Private Limited, operates from its registered office in Mumbai. The clarification was signed by Chief Financial Officer Dharmesh Dattani and made available on the company's website at www.laxmidentallimited.com for stakeholder reference. We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better. Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians. As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.